-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Announcement of Awards: Wallace H. Coulter Award for Lifetime Achievement in Hematology, ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, and the Outstanding Service Award

Program: Marquee Sessions
Sunday, December 8, 2024: 1:30 PM-2:00 PM
Hall B (San Diego Convention Center)
Chair:
Mohandas Narla, DSc, New York Blood Center
Disclosures:
No relevant conflicts of interest to declare.

WALLACE H. COULTER AWARD FOR LIFETIME ACHIEVEMENT IN HEMATOLOGY
ASH will recognize Éliane Gluckman, MD, PhD, of the University of Paris, for a lifetime of achievement in cord blood transplantation. She performed the world’s first human cord blood transplant, which established cord blood as an alternative stem cell source for patients in need of hematopoietic cell transplantation and shortened the delay between donor identification and transplant. She was drawn to hematology because of its potential for growth and innovation. Her first residency position affirmed her passion and interest in Fanconi anemia and sickle cell disease (SCD). From 1988, she led cord blood research as medical director of the bone marrow transplant service and head of the department of hematology at the Saint-Louis Hospital.
Her continued impact includes contributions to understanding disorders such as aplastic anemia, Fanconi anemia, and SCD through the design of new conditioning protocols that are used to prepare patients for stem cell transplantation. Her current project examines immunogenetic factors that could predict the outcomes and probability of finding a donor for stem cell transplants in people living with SCD and other hereditary disorders.

ASH MENTOR AWARDS
ASH will recognize Stephen Nimer, MD, of the Sylvester Comprehensive Cancer Center, for his impact on more than 100 hematology trainees with his community-focused mentorship. He serves as a role model for trainees and instills in them the importance of thinking critically and embracing challenges. His willingness to provide feedback, dedication to seizing growth opportunities, and catchy “Nimer-isms” have helped propel mentees into thriving careers.
ASH will recognize Charles Schiffer, MD, of the Karmanos Cancer Institute, for his ability to lead by example and challenge trainees to remain curious, seize opportunities, and think creatively. His mentees have described him as a one-of-a-kind generational teacher and a “mentor of mentors.” He has trained many clinical investigators whose contributions have substantially influenced leukemia and cancer research and improved patient outcomes.

ASH AWARD FOR LEADERSHIP IN PROMOTING DIVERSITY
ASH will recognize James George, MD, of the University of Oklahoma, for his leadership in building a stronger, more diverse hematology workforce. During his ASH presidency in 2005, ASH collaborated with the Harold Amos Medical Faculty Development Program (AMFDP) to create ASH-funded AMFDP positions. Since then, ASH has supported nearly 30 recipients, many of whom have risen to the ranks of senior faculty. Dr. George was also a strong supporter of the ASH Minority Medical Student Award Program (MMSAP), which provides research support for medical students underrepresented in medicine to encourage them to pursue hematology. MMSAP has supported more than 300 research opportunities.

OUTSTANDING SERVICE AWARD
ASH will recognize Mary Hulihan, DrPH, of the Centers for Disease Control and Prevention’s National Center on Birth Defects & Developmental Disabilities for her work related to sickle cell disease (SCD) and thalassemia. She is the project officer for several cooperative agreements connected to SCD, including the SCD Collection program which has grown tremendously under her leadership. The information generated from the SCD Collection program has informed many aspects of ASH’s SCD initiative and provided valuable information to the greater sickle cell community. Throughout her career, Dr. Hulihan has volunteered to present at many ASH meetings and is an ongoing volunteer with the SCD Learning Community and a long-time co-chair of the ASH-managed SCD Coalition Working Group on Access to Care. She is also an active member of the Department of Health and Human Services Interagency Working Group on SCD and has been instrumental in driving much-needed collaboration across federal agencies with sickle cell programs.

See more of: Marquee Sessions